PharmiWeb1h
PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments Denice Torres, J.D., former Board Member of Karuna Therapeutics and accomplished healthcare ...
PharmiWeb1h
Jo Goodman Joins Celerion as Vice President of Bioanalytical Services
Celerion, a leading clinical research organization, specializing in early clinical research and bioanalytical services, today announced the appointment of Jo Goodman as vice president of bioanalytical ...
PharmiWeb1h
Leica Microsystems adds cutting-edge light sheet solutions to its portfolio with the integration of Viventis Microscopy
Patented Viventis light sheet solution enables detailed volumetric imaging to explore life in its entirety Wetzlar, Germany, May 7, 2024 Leica Microsystems, a leader in microscopy and scientific ...
PharmiWeb1h
TMC welcomes Simon Estcourt as new Chief Executive Officer (CEO) to spearhead next phase of development
TMC welcomes Simon Estcourt as new Chief Executive Officer (CEO) to spearhead next phase of developmentHampshire, UK — 7 May 2024TMC Pharma Services Ltd., an established global product development and ...
PharmiWeb1h
Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region
Biocartis (Mechelen, Belgium) announced an expansion of its collaboration with Merck Serono Middle East and Merck Saudi Ltd., both affiliates of Merck KGaA (“Merck”). The collaboration aims to improve ...
PharmiWeb1h
National approval for MOB-015 in all 13 countries
Moberg Pharma AB (OMX:MOB) hereby announces that MOB-015 has received national approvals for all countries included in the decentralized procedure. MOB-015 is thus approved for the treatment of mild ...
PharmiWeb1h
IRLAB Enters a Development Collaboration for IRL757 as a Novel Treatment for Apathy
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLYGOTHENBURG, SE / ACCESSWIRE / May 7, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, ...
PharmiWeb1h
NovAccess Global Advisory on Annual Meeting of Shareholders
CLEVELAND, OH / ACCESSWIRE / May 7, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the postponement of its ...
PharmiWeb2h
Glidewell Announces 2024 Guiding Leaders Cohort
Twenty-five women dentists were selected for the exclusive business and leadership development program.NEWPORT BEACH, CA / ACCESSWIRE / May 7, 2024 / On April 5, 2024, a Glidewell selection committee ...
PharmiWeb2h
CLOUD DX Signs Multi-Year Contract with Provincial Health Authority
This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the Yukon and Prince Edward Island. News in Summary· After a ...
PharmiWeb2h
M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share
Dividend/ForecastM1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share07-May-2024 / 16:28 CET/CESTDisclosure of an inside information acc ...
PharmiWeb3h
Radiotherapy-Induced Nausea and Vomiting Treatment Market Size, Share and Growth Opportunities
The Radiotherapy-Induced Nausea and Vomiting Treatment Market is undergoing significant transformations, influenced heavily by its interconnectedness with various end-use industries. These industries ...